Dezhan Healthcare Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Wei Liu

Chief executive officer

CN¥4.0m

Total compensation

CEO salary percentage	n/a
CEO tenure	7.6yrs
CEO ownership	0.2%
Management average tenure	no data
Board average tenure	2.8yrs

Recent management updates

Recent updates

We Like The Quality Of Dezhan Healthcare's (SZSE:000813) Earnings

Apr 18

CEO

Wei Liu (53 yo)

7.6yrs

Tenure

CN¥3,980,000

Compensation

Mr. Wei Liu is Co-Chairman & GM of Dezhan Healthcare Company Limited from October 28, 2016.

Board Members

Name	Position	Tenure	Compensation	Ownership
Wei Liu	Co-Chairman & GM	7.6yrs	CN¥3.98m	0.23% CN¥ 13.9m
Weihong Sun	Independent Director	2.8yrs	CN¥180.00k	no data
Bin Wu	Independent Director	2.8yrs	CN¥180.00k	no data
Hailin Yan	Non-Independent Director	2.8yrs	no data	no data
Zheming Wei	Chairman	7.6yrs	no data	0.021% CN¥ 1.3m
Feng Han	Director	2yrs	no data	no data
Sinian Chou	Non-Independent Director	2.8yrs	CN¥60.00k	no data
Xin An Wang	Independent Director	2.8yrs	no data	no data
Ping Li	Employee Supervisor	2.8yrs	no data	no data

2.8yrs

Average Tenure

53yo

Average Age

Experienced Board: 000813's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Dezhan Healthcare Management

Management criteria checks 1/4

Key information

Recent management updates

Dezhan Healthcare Company Limited, Annual General Meeting, May 08, 2024

High number of new and inexperienced directors

Recent updates

We Like The Quality Of Dezhan Healthcare's (SZSE:000813) Earnings

Full year 2023 earnings released: EPS: CN¥0.038 (vs CN¥0.021 loss in FY 2022)

Dezhan Healthcare Company Limited, Annual General Meeting, May 08, 2024

Dezhan Healthcare Company Limited to Report Q1, 2024 Results on Apr 25, 2024

Dezhan Healthcare Company Limited to Report Fiscal Year 2023 Results on Apr 12, 2024

Third quarter 2023 earnings released: EPS: CN¥0.033 (vs CN¥0 in 3Q 2022)

Dezhan Healthcare Company Limited to Report Q3, 2023 Results on Oct 26, 2023

Second quarter 2023 earnings released: CN¥0.004 loss per share (vs CN¥0.016 profit in 2Q 2022)

First quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.014 in 1Q 2022)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0 (vs CN¥0.01 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.016 (vs CN¥0.017 in 2Q 2021)

Full year 2021 earnings: EPS and revenues miss analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.01 (vs CN¥0.026 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.017 (vs CN¥0.041 in 2Q 2020)

Dezhan Healthcare Company Limited Approves Final Dividend Implementation Plan (A Shares) for 2020, Payable on June 1, 2021

Dezhan Healthcare Company Limited Announces the Profit Distribution Proposal for 2020

First quarter 2021 earnings released: EPS CN¥0.029 (vs CN¥0.041 in 1Q 2020)

Investor sentiment improved over the past week

New 90-day low: CN¥3.98

Investor sentiment deteriorated over the past week

New 90-day low: CN¥5.85

Dezhan Healthcare's Controlling Shareholder Plans to Sell Stake in the Company

New 90-day high: CN¥6.85

Third quarter earnings released

New 90-day low: CN¥6.05

First half earnings released

Dezhan Healthcare Company Limited to Report First Half, 2020 Results on Aug 29, 2020

Dezhan Healthcare Company Limited (SZSE:000813) completed the acquisition of 70% stake in Beijing Changjiang Mai Medical Technology Co., Ltd from Dai Yanzhen.

CEO

Tenure

Compensation

Board Members

Average Tenure

Average Age